The authorization of bortezomib will enhance the company’s ability to deliver advanced cancer solutions in Southeast Asia
Presidential Symposium for NIAGARA will highlight practice-changing impact of a perioperative Imfinzi-based regimen in bladder cancer
Pegfilgrastim is a Pegylated form of the recombinant human granulocyte colony-stimulating factor (G-CSF) analogue Filgrastim
Our centers are performing as expected or even better
Performed an autologous bone marrow transplant, using the patient’s own cells to reduce the chances of infection and rejection
Boehringer Ingelheim aims to develop this program as a potential key centerpiece component for its immuno-oncology portfolio
Mahatma Gandhi Cancer Hospital & Research Institute has emerged as the leading provider of comprehensive cancer care in Viza
First immunotherapy regimen before and after surgery to extend survival in bladder cancer
Subscribe To Our Newsletter & Stay Updated
